Pharmacy Updates

 

11/2020 – 2021 Formulary Update

08/2020 – MedWatch Safety Alert – FDA Recommends Health Care Professionals Discuss Naloxone with All Patients when Prescribing Opioids or Medicines to Treat Opioid Use Disorder.

02/2020 – Newsletter – Provider Formulary Updates.

11/2019 – 2020 Provider Notification of Opioid Drug Management Program (DMP).

11/2019 – HHS Guide for Appropriate Tapering or Discontinuation of Long-Term Opioid Use.

07/2019 – Newsletter – Provider Formulary Updates.

12/2018 – 2019 Provider notification of Opioid Drug Management Program.

 

Provider Prevention of Unauthorized Prescribing

To learn more click below:

• CMS: Partners in Integrity-What Is a Prescriber’s Role in Preventing the Diversion of Prescription Drugs  https://www.cms.gov/medicare-medicaid-coordination/fraud-prevention/medicaid-integrity-education/provider-education-toolkits/downloads/prescriber-role-drugdiversion.pdf
• E-FORCSE®, Florida’s Prescription Drug Monitoring Program Home Page http://www.floridahealth.gov/statistics-and-data/e-forcse/

 

Influenza Season 2020-2021 Update

08/2020- Influenza Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2020-21 Summary.

 

 

Recalls and Drug Safety Communications

07/2020 – Drug Recall Notice Metformin Hydrochloride ER 500 mg and 1000 mg tablets by Lupin Pharmaceuticals.

07/2020 – Drug Recall Notice Granule Pharmaceuticals Metformin Hydrochloride ER 750 mg tablets.

06/2020 – Drug Recall Notice Teva Metformin Hydrochloride ER 500 mg and 750 mg tablets.

06/2020 – Drug Recall Notice Amneal Metformin Hydrochloride ER 500 mg and 750 mg tablets.

05/2020 – Drug Recall Notice NP Thyroid tablets.

04/2020 – Drug Recall Notice Tetracycline 250mg and 500mg capsules.

04/2020 – Drug Recall Notice ALL Ranitidine and ZANTAC products.

01/2020 – Drug Recall Notice Ranitidine 150mg and 300mg capsules (Appco)

01/2020 – FDA warns about serious breathing problems with gabapentin and pregabalin when used with CNS depressants in patients with lung problems.

01/2020 – Drug Recall Notice Aurobindo Mirtazapine 7.5 mg tablets lot #03119002A3

12/2019 – Drug Recall Notice Expansion Amneal Ranitidine 150mg and 300mg Tablets and 15mg/mL syrup

11/2019 – Drug Recall Notice Amneal Ranitidine 150mg and 300mg Tablets and 15mg/mL syrup

11/2019 – Drug Recall Notice Aurobindo Ranitidine 150mg and 300 mg capsules, 150mg tablets and 15mg/mL syrup WEB

11/2019 – Drug Recall Notice Novitium  Ranitidine 150 mg and 300 mg tablets

11/2019 – Drug Recall Notice Lannett  Ranitidine 15mg/mL syrup

10/2019 – Drug Recall Notice Mylan Alprazolam products

10/2019 – Drug Recall Notice Dr. Reddy’s Ranitidine products

10/2019 – Drug Recall Notice Sandoz Rantidine Capsules

10/2019 – FDA Drug Safety Communication – Zantac (Ranitidine)

09/2019 – Drug Recall Notice – NATPARA (Parathyroid Hormone) for Injection

09/2019 – FDA Drug Safety Communication: Xeljanz, Zeljanz XR

08/2019 – Over the Counter (OTC) recall of multiple Altaire Ophthalmic products at CVS

08/2019 – Drug Recall Notice Relpax 40 mg tablets

07/2019 – Drug Recall – Altaire Pharmaceuticals – Ophthalmics

05/2019 – Drug Recall Notice Losartan and Losartan HCTZ

05/2019 – Drug Recall Losartan

05/2019 – FDA Drug Safety Communication for Prescription Insomnia Medicines: New Boxed Warning – Due to Risk of Serious Injuries Caused by Sleepwalking, Sleep Driving and Engaging in Other Activities While Not Fully Awake

04/2019 – Drug Recall Notice – Losartan Legacy MFXR

04/2019 – Drug Recall Notice – Valsartan

04/2019 – Drug Recall Notice Losartan and Losartan HCTZ

04/2019 – Drug Recall Notice Losartan

04/2019 – Drug Recall Notice Losartan HCTZ

01/2019 – Drug News and Alerts/ Recall Notice for  Irbesartan and Irbesartan HCTZ Tablets.

01/2019 – Drug News and Alerts/Recall Notice for Losartan Potassium tablets.

 

 

 

 

H4140_PRWSNOTIF_C
Last Updated: 11/25/2020